Lamazhapova G P, Syngeeva E V, Kozlova T S, Zhamsaranova S D
East Siberia State University of Technology and Management, Ulan-Ude.
Vopr Pitan. 2017;86(1):76-84. doi: 10.24411/0042-8833-2017-00024. Epub 2016 Dec 28.
The research is aimed at obtaining a concentrate of polyunsaturated fatty acids (PUFA) in liposomal form and developing possible ways of PUFA application in manufacturing functional food products. The PUFA concentrate was obtained from the fat of the Baikal seal by method of complexing with urea. We prepared a liposomal form of PUFA concentrate by evaporating organic solvent from the solution of lipids to form a thin lipid film with addition of buffer solution and further extrusion of the obtained emulsion. We defined the size of liposomal particles by method of turbidimetry. We identified the fatty acid composition of the samples by gas-liquid chromatography using a chromatographymass spectrometer. Biomedical research was conducted on 30 adult male Wistar rats with initial weight of 130-150 g. We induced atherogenic experimental hyperlipemia in rats by adding 5% cholesterol, 0.3% of 6-methyl-2-thiouracil, 1% cholic acid and 5% of lard to their normal diet for 21 days. We used an automatic biochemical analyzer to define total cholesterol (TC), triglycerides (TG), high density lipoprotein (HDL), low density lipoprotein (LDL), very low density lipoproteins (VLDL) in blood serum. As a result of the experiment, we obtained a concentrate from the seal fat with content of essential PUFA 12.2% of total fatty acids in which the ratio of ω-6:ω-3 was 1.3:1. We obtained the liposomal form of the PUFA concentrate, with the average size of the liposomes ranging from 144 to 158 nm. We have established that the blood serum of the animals with induced hyperlipidemia, which orally took the liposomal form of PUFA concentrate for 14 days in a dose of 20 mg/kg body weight, showed the decrease of total cholesterol content of LDL and VLDL, while HDL increased to the parameters in intact animals. This indicated a normalization of the lipid profile in rats and the lipid-lowering effect of the concentrate. Also, we have studied the possibility of enriching wheat bread with essential fatty acids by replacing some part of the water with the liposomal form of PUFA concentrate. The use of this additive increased the output volume of bread by 14%, intensified the crust color and didn't affect the organoleptic indicators of bread quality. Fatty acid analysis of the lipids in bread showed that after adding 3 g of PUFA concentrate in liposome form per 100 g of flour increased the content of ω-3 PUFA by 3.2 fold (191 mg per 100 g of bread), with the ratio of ω-6:ω-3 PUFA being 5.8:1. Thus, bread enriched with PUFA concentrate in liposome form can be positioned as a functional food product that contains ω-3 PUFA in an amount of 19.1% of the recommended daily intake in 100 g of final product and also as a product with optimal PUFA ratio of ω-6:ω-3.
该研究旨在获得脂质体形式的多不饱和脂肪酸(PUFA)浓缩物,并探索PUFA在功能性食品生产中的应用途径。通过与尿素络合的方法从贝加尔海豹脂肪中获得了PUFA浓缩物。我们通过从脂质溶液中蒸发有机溶剂以形成脂质薄膜,并加入缓冲溶液,然后对所得乳液进行进一步挤压,制备出了PUFA浓缩物的脂质体形式。我们通过比浊法确定了脂质体颗粒的大小。使用气相色谱 - 质谱联用仪通过气液色谱法鉴定了样品的脂肪酸组成。对30只初始体重为130 - 150 g的成年雄性Wistar大鼠进行了生物医学研究。通过在大鼠正常饮食中添加5%胆固醇、0.3% 6 - 甲基 - 2 - 硫脲、1%胆酸和5%猪油21天,诱导大鼠产生致动脉粥样硬化实验性高脂血症。我们使用自动生化分析仪测定血清中的总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、极低密度脂蛋白(VLDL)。实验结果表明,从海豹脂肪中获得的浓缩物中,必需PUFA含量占总脂肪酸的12.2%,其中ω - 6:ω - 3的比例为1.3:1。我们获得了PUFA浓缩物的脂质体形式,脂质体的平均大小在144至158纳米之间。我们发现,诱导高脂血症的动物口服脂质体形式的PUFA浓缩物,剂量为20 mg/kg体重,持续14天,其血清中LDL和VLDL的总胆固醇含量降低,而HDL增加到正常动物的参数水平。这表明大鼠的脂质谱正常化以及浓缩物具有降脂作用。此外,我们还研究了用PUFA浓缩物的脂质体形式替代部分水来富集小麦面包中必需脂肪酸的可能性。使用这种添加剂使面包的产量提高了14%,加深了面包皮的颜色,并且不影响面包质量的感官指标。对面包中的脂质进行脂肪酸分析表明,每100 g面粉中添加3 g脂质体形式的PUFA浓缩物后,ω - 3 PUFA的含量增加了3.2倍(每100 g面包中含191 mg),ω -